Murae Organisor Ltd
Incorporated in 2012, Murae Organisor Ltd
is in the business of pharma commodities
trading[1]
- Market Cap ₹ 130 Cr.
- Current Price ₹ 1.40
- High / Low ₹ 2.72 / 1.03
- Stock P/E 27.6
- Book Value ₹ 2.85
- Dividend Yield 0.00 %
- ROCE 0.79 %
- ROE 0.13 %
- Face Value ₹ 2.00
Pros
- Stock is trading at 0.49 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -45.0% over past five years.
- Company has a low return on equity of 6.02% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 1,543 days.
- Working capital days have increased from 2,490 days to 6,342 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 9m | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 0 | 9 | 19 | 23 | 35 | 51 | 55 | 41 | 21 | 14 | 3 | 340 | |
0 | 0 | 9 | 18 | 23 | 34 | 47 | 54 | 49 | 25 | 13 | 4 | 333 | |
Operating Profit | 0 | 0 | 0 | 1 | 0 | 2 | 3 | 1 | -8 | -4 | 1 | -1 | 6 |
OPM % | 2% | 3% | 2% | 4% | 7% | 2% | -19% | -21% | 7% | -44% | 2% | ||
0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 9 | 8 | 2 | 2 | 0 | |
Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit before tax | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 3 | 3 | 0 | 6 |
Tax % | 31% | 44% | 33% | 27% | 27% | 26% | 25% | 28% | 29% | 29% | |||
0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 2 | 2 | 0 | 5 | |
EPS in Rs | 0.20 | 0.32 | 0.46 | 0.83 | 0.04 | 0.00 | 0.05 | 0.05 | 0.00 | 0.04 | |||
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | -45% |
3 Years: | -60% |
TTM: | 8246% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -50% |
3 Years: | -18% |
TTM: | 654% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -24% |
3 Years: | -31% |
1 Year: | -20% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 6% |
3 Years: | 6% |
Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.01 | 0.01 | 0.01 | 0.11 | 0.11 | 0.31 | 0.31 | 6 | 6 | 12 | 12 | 49 | 139 |
Reserves | 0 | 0 | 1 | 1 | 1 | 5 | 6 | 8 | 8 | 4 | 6 | 6 | 126 |
0 | 0 | 1 | 2 | 2 | 7 | 10 | 9 | 11 | 9 | 9 | 0 | 260 | |
0 | 0 | 3 | 6 | 7 | 7 | 8 | 12 | 2 | 3 | 1 | 64 | 24 | |
Total Liabilities | 0 | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 548 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
0 | 0 | 5 | 9 | 11 | 19 | 23 | 32 | 27 | 28 | 28 | 120 | 548 | |
Total Assets | 0 | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 548 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 0 | -2 | -0 | 0 | -7 | -0 | -3 | -7 | 3 | 0 | -16 | |
0 | 0 | -0 | -0 | -0 | -0 | -0 | -3 | 3 | 0 | 0 | -0 | |
0 | 0 | 2 | 1 | -0 | 7 | 1 | 7 | 3 | -3 | -0 | 28 | |
Net Cash Flow | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -1 | -0 | -0 | 12 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 125 | 87 | 56 | 111 | 78 | 112 | 95 | 261 | 217 | 1,543 | ||
Inventory Days | 71 | 78 | 108 | 91 | 86 | 97 | 122 | 179 | 392 | 1,439 | ||
Days Payable | 113 | 107 | 83 | 77 | 54 | 83 | 10 | 18 | -25 | 7 | ||
Cash Conversion Cycle | 82 | 58 | 82 | 125 | 111 | 126 | 207 | 422 | 635 | 2,975 | ||
Working Capital Days | 81 | 54 | 58 | 116 | 98 | 126 | 222 | 431 | 698 | 6,342 | ||
ROCE % | 0% | 22% | 21% | 22% | 25% | 24% | 17% | 4% | 12% | 12% | 1% |
Documents
Announcements
-
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, 22Nd May, 2025
14 May - Board meeting on 22 May 2025 to approve audited financial results for FY 2024-25.
-
Rumour verification - Regulation 30(11)
14 May - MURAE Organisor denies false social media claims; confirms only 1:1 stock split; warns legal action possible.
-
Intimation Of Proposed Acquisition Of Land For Agricultural And Industrial Expansion & Investment Of INR 250 Million
12 May - Proposed INR 250M land acquisition in Gujarat for pomegranate farming and distillery expansion.
-
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
7 May - Company changed registered office address within Ahmedabad city effective 7th May 2025.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. 7Th May, 2025
7 May - Company changed registered office address within Ahmedabad city effective 7th May 2025.
Business Overview:[1][2][3]
a) MOL is in the business of manufacturing Pharmaceutical, Nutraceutical, Ayurvedic
Herbal products, and trading of pharma
products.
b) It acts as a commission agent in pharma products etc.
c) It provides premium cattle feed which is formulated to support livestock health and performance, while its fertilizers and chemicals are designed to optimize crop yields and ensure safety.
d) It also offers expertise in the gold sector, providing insights and services related to this precious metal